Cardiff Oncology (CRDF)
(Delayed Data from NSDQ)
$3.58 USD
+0.10 (2.87%)
Updated May 14, 2024 04:00 PM ET
After-Market: $3.58 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.25 | -1.01% |
Earnings Summary
For their last quarter, Cardiff Oncology (CRDF) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.25 per share. This reflects a positive earnings surprise of 12.00%. Look out for CRDF's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for CRDF
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
CRDF: What are Zacks experts saying now?
Zacks Private Portfolio Services